Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 68788-8145 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - divalproex fig1
Figure 2 - divalproex fig2
Figure 3 - divalproex fig3
This figure (Figure 3) displays the reduction in CPS rate categorized by various levels of dosage (High Dose and Low Dose) in percentage of patients. The figure indicates the proportion of patients who improved, had no change, or worsened. There is no further information available.*
Figure 4 - divalproex fig4
The text describes the mean 4-week migraine rates for Placebo and Divalproex Sodium delayed-release tablets in Study 1 and Study 2. It also indicates that the mean dose of Divalproex Sodium delayed-release tablets in Study 1 was 1,087 mg/day, while in Study 2 it was either 500 or 1,000 mg/day.*
Divalproex Sodium DR Tablets 250mg - divalproex fig7
This text appears to be a medication label for Divalproex Sodium DR Tablets 250mg. It warns that the transfer of the drug to anyone other than the patient is prohibited by federal law. It provides information on the ingredients, dosage, and storage instructions. It also includes an expiration date and lot number.*
Chemical Structure - divalproex str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.